Health Tech Invest Morning

On Wednesday 21 October, the Health Tech Invest Morning brings together startups, scale-ups, researchers, healthcare professionals and investors around one central question: how do promising health technologies become solutions that create real impact?

• Bas Sturm (VLAIO) will moderate a morning of keynotes and reverse pitches on funding, regulation, validation and adoption.
• Gert Van Assche and Bart De Greef (KU Leuven / UZ Leuven) will ask whether we are investing in the right health technologies, with a focus on prevention, early detection and continuous monitoring.
• Jan Schrooten (Antleron) will explore how regenerative medicine can move from research to scalable healthcare solutions.
• Olivier Taelman (Nyxoah) will share what it takes to grow a capital-intensive health tech company from first implant to commercial scale.
  

During the reverse pitches, Katrin Geyskens (Capricorn Partners), Nathalie Van Bruaene (PMV) and Marrit van den Heuvel (imec.xpand) will take the stage to explain what they look for in health tech investments and what makes them say yes or no.

This is an open session, for anyone who is interested. However, the morning leads into the exclusive Deep Tech Investors Lunch (on invitation only), focused on concrete investment and collaboration opportunities. Those who don't join this lunch, will be offered a different lunch at the event.